The pharmaceutical industry in Saudi Arabia

Saudi Arabia started its path to improve traceability and visibility in the pharma supply chain in 2015, making medicines safer and preventing counterfeiting through serialization. Unlike in Europe, a complete track-and-trace system, including aggregation processes, is introduced.

Introducing a track-and-trace system in Saudi Arabia is part of the Saudi government’s Vision 2030 program. By 2030, Saudi Arabia wants to track all medicines and healthcare products registered for human use, domestically and internationally.

Designation: Drug Track and Trace System for Pharmaceutical Products (RSD)

Competent authority: Saudi Food and Drug Authority (SFDA)

Products: All medicines for humans and animals

Code type: GS1 Data Matrix

Aggregation: Yes, according to GS1 standards

Timeframe: Start December 2015, serialization from 2017, a complete implementation in 2022.

Why SoftGroup?

•  Because of our experience working with large-scale track and trace regulations around the world
•  Since we work for your future-ready solution that can be adapted to the specifics of your business processes
•  As we’ll dedicate a team to your project

How can we help?

  SoftGroup provides an end-to-end solution for complying with all requirements of the Saudi Arabia National Track & Trace System – RSD digital platform.

  The solution ensures a connection and data exchange between the National Track & Trace System – RSD digital platform and all shareholders (MAHs, Manufacturers, Importers, Distributors, etc.).

  Despite your role within the supply chain (MAHs, Manufacturer, Importer or distributor), you can easily upload the required product master data (PMD) of imported or produced medicines, herbs, and health drugs and publish the product pack data (PPD), including serial and aggregation reports of all packaging levels.